Richard Quek

Janus Kinase 3–Activating Mutations Identified in Natural Killer/T-cell Lymphoma

Ghee Chong Koo, Soo‐Yong Tan, Tiffany Tang et al. · Cancer Discovery · 2012 · 267 citations · Full text

Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients

Valerie Chew, Charlene Tow, Marissa Teo et al. · Journal of Hepatology · 2009 · 254 citations

Hepatology, Hepatocellular Carcinoma Patients, Hepatocellular Carcinoma +10

Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors

Richard Quek, Qian Wang, Jeffrey A. Morgan et al. · Clinical Cancer Research · 2010 · 158 citations

Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab

Lynette Ngo, Siew Wan Hee, L C Lim et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 104 citations

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

Yu Xuan Koo, Matthew Zirui Tay, Yii Ean Teh et al. · Annals of Hematology · 2011 · 104 citations

Vaccination, Hepatology, Viral Hepatitis +8